Antithrombotic Therapy Antiplatelet

active
URL
http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1110.61
Version
20230217
PublisherTJC EH StewardDate2023-02-17T01:03:27-05:00Purpose

(Clinical Focus: The purpose of this value set is to represent concepts of medications that are antiplatelet medications used to reduce stroke mortality and morbidity.),(Data Element Scope: This value set may use a model element related to Medication.),(Inclusion Criteria: Includes concepts that represent a medication that is an antithrombotic medication, including oral, rectal, and injectable dose forms.),(Exclusion Criteria: Excludes concepts that represent enoxaparin and heparin generally given for VTE prophylaxis.)

Expansion
<<>>>
CodeDisplaySystem
994528http://www.nlm.nih.gov/research/umls/rxnorm
212033http://www.nlm.nih.gov/research/umls/rxnorm
994430http://www.nlm.nih.gov/research/umls/rxnorm
1536675http://www.nlm.nih.gov/research/umls/rxnorm
763116http://www.nlm.nih.gov/research/umls/rxnorm
308278http://www.nlm.nih.gov/research/umls/rxnorm
308297http://www.nlm.nih.gov/research/umls/rxnorm
1250907http://www.nlm.nih.gov/research/umls/rxnorm
994535http://www.nlm.nih.gov/research/umls/rxnorm
1811632http://www.nlm.nih.gov/research/umls/rxnorm
308363http://www.nlm.nih.gov/research/umls/rxnorm
900528http://www.nlm.nih.gov/research/umls/rxnorm
763111http://www.nlm.nih.gov/research/umls/rxnorm
1537029http://www.nlm.nih.gov/research/umls/rxnorm
308416http://www.nlm.nih.gov/research/umls/rxnorm
1722689http://www.nlm.nih.gov/research/umls/rxnorm
994435http://www.nlm.nih.gov/research/umls/rxnorm
308409http://www.nlm.nih.gov/research/umls/rxnorm
1666332http://www.nlm.nih.gov/research/umls/rxnorm
702316http://www.nlm.nih.gov/research/umls/rxnorm